Skip to content

Cryoneurolysis versus steroid infiltration for treatment of lumbar facet joint syndrome: a randomized controlled double-blind study

Cryoneurolysis versus steroid infiltration for treatment of lumbar facet joint syndrome: a randomized controlled double-blind study - KryoRCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000659
Enrollment
30
Registered
2011-01-03
Start date
2011-02-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M54.5 M48.99

Interventions

Group 1: Cryoneurolysis of the affected lumbar facet joints with 2 x 3 min -60 bis -70° C Group 2: steroid infiltration of the affected lumbar facet joints with 4 mg dexamethason

Sponsors

Interdisziplinäres Schmerzzentrum Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: • chronic low back pain • twofold lumbar facet joint block with at least 50 % pain reduction on the NAS (numeric analog scale) during the local anaesthetic effect • written consent after detailed explanation and enough time for consideration

Exclusion criteria

Exclusion criteria: • radicular pain • lumbar instability • Coagulopathy • steroid intolerance • severe insulin-dependent diabetes mellitus • medium or major depressive episode • dementia • considerable psychosocial stress factors • whole body pain

Design outcomes

Primary

MeasureTime frame
mean, minimal and maximal pain scores on the NAS twelve weeks after cryoneurolysis

Secondary

MeasureTime frame
• quality of life • medication use • depressivity/anxiety • second cryoneurolysis after twelve weeks • mean, minimal and maximal pain scores on the NAS half a year, one year and two years after cryoneurolysis

Countries

Germany

Contacts

Public ContactTilman Wolter

Interdisziplinäres Schmerzzenztrum Universitätsklinikum Freiburg

tilman.wolter@uniklinik-freiburg.de+49/761/2705203

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026